1[1]Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta [J]. Cancer Res, 1997,57(11):2124-2129.
2[2]Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997,15(4):356-362.
3[3]Li J, Yen C, Liaw D,et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[J]. Science, 1997,275(5308):1943-1947.
4[4]Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger,phosphatidylinositol 3,4,5-trisphosphate[J]. J Biol Chem,1998,273(22):13375-13378.
5[5]Forgacs E, Biesterveld E J, Sekido Y, et al. Mutation analysis of the PTEN/MMAC1 gene in lung cancer[J]. Oncogene, 1998,17(12):1557-1565.
6[6]Yaginuma Y, Yamashita J, Ishiya T, et al. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers[J]. Mol Carcinog, 2000,27(2):110-116.
8[8]Rubin MA, Gerstein A, Reid K, et al. 10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N +) versus lymph node-negative (pT2-3,N0) prostate cancer[J]. Hum Pathol, 2000,31(4):504-508.
9[9]Yao YJ, Ping XL, Zhang H, et al. PTEN/MMAC1 mutations in hepatocellular carcinomas[J]. Oncogene, 1999,18(20):3181-3185.
10[10]Yokomizo A,Tindall DJ,Drabkin H,et al. PTEN/MMAC1 mutations identified in small cell, but not in non-small lung cancers[J]. Oncogene, 1998,17(4)475-479.
2Yaginuma Y,Yamashita T,Ishiya T,et al.Abnormal structure and expression of PTEN MMAC1 gene in human uterine cancers[].Molecular Carcinogenesis.2000
3Risinger JI,Hayes K,Maxwell GL,et al.PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics[].Clinical Cancer Research.1998
4Tashiro H,Blazes MS,Wu R,et al.Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies[].Cancer Research.1997
5Maxwell GL,Risinger JI,Tong B,et al.Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers[].Gynecologic Oncology.1998
6Kurose K,Zhou XP,Araki T,et al.Frequent loss of PTENexpression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas[].American Journal of Pathology.2001
1Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms[J]. Proc Natl Acad Sci USA, 1989, 86(8):2766
2Orita M, Suzuki Y, Sekiya T, et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction[J]. Genomics, 1989, 5(4):874
3Yap EP, McGee JO. Nonisotopic SSCP detection in PCR products by ethidium bromide staining[J]. Trends Genet, 1992, 8(2):49
4Atha DH, Wenz HM, Morehead H, et al. Detection of p53 point mutations by single strand conformation polymorphism: analysis by capillary electrophoresis[J]. Electrophoresis, 1998, 19(2):172
5Righetti PG, Gelfi C. Capillary electrophoresis of DNA for molecular diagnostics[J]. Electrophoresis, 1997, 18(10):1709
6Hayashi K, Yandell DW. How sensitive is PCR-SSCP[J]? Hum Mutat, 1993, 2(5):338
7Maruya E, Saji H, Yokoyama S. PCR-LIS-SSCP (Low ionic strength single-stranded conformation polymorphism)--a simple method for high-resolution allele typing of HLA-DRB1, -DQB1, and -DPB1[J]. Genome Res, 1996, 6(1):51
8Lynas C, Howe D. Simple, reliable detection of T cell clones by PCR-LIS-SSCP analysis of TCRgamma rearrangement[J]. Mol Cell Probes, 1998, 12(1):41
9Abba MC, Gomez MA, Golijow CD. HLA-DQA1 allele typing by nonisotopic PCR-LIS-SSCP[J]. Braz J Med Biol Res, 2001, 34(7):867
10Sambrook J, Fritsh EF, Maniatis T. Molecular Cloning: a laboratory manual[M]. 2nd Ed. New York, Cold Spring Harbor Laboratory Press, 1989, 382
